Is TransMedics Group Stock a Buy?

This organ transplant specialist is down, but still has plenty of signs of life.TransMedics Group (TMDX -4.71%) has emerged as a medical devices industry leader, capturing strong growth and climbing profitability from its organ transplant delivery system. Since the company's 2019 initial public offering, the stock has returned a massive 285%.That said, the early success hasn't been achieved without some stumbling blocks. The company's latest quarterly update came in below Wall Street estimates, and shares a ...